期刊文献+

治疗性血液成分单采术在血液病中的应用及疗效评价 被引量:10

下载PDF
导出
摘要 治疗性血液成分单采术是借助连续流动的血细胞分离机,分离和去除患者循环血液中某些病理成分,根据治疗目的回输其正常成分或补充置换液或正常血浆,包括血细胞单采、血液成分置换及血液成分调整[1]。其可以快速改变血液中组成成分,对于血液中血细胞数目过高或血浆异常疾病进行快速而有效的治疗,为进一步药物治疗提供条件[2]。在血液系统疾病中,多种因素所致的血细胞明显升高的疾病,如高白细胞的急慢性白血病、真性红细胞增多症。
出处 《中国现代医药杂志》 2016年第7期28-30,共3页 Modern Medicine Journal of China
  • 相关文献

参考文献7

  • 1夏云金,周梅玲,万楚成,章正华,张霞,姜铧,龙志国.治疗性血小板单采术在血小板增多症患者中的应用[J].血栓与止血学,2011,17(6):266-268. 被引量:10
  • 2鲍立,江滨,王德炳,陈珊珊,邱镜滢,卢锡京,黄晓军,陆道培.高白细胞急性早幼粒细胞白血病的临床研究[J].中国综合临床,2007,23(7):606-608. 被引量:5
  • 3Xinxin Jiang,Jian Feng,Youxin Ye.??Double‐Filtration Plasmapheresis for Treatment of Acute Renal Failure in a Multiple Myeloma Patient(J)Ther Apher Dial . 2014 (3)
  • 4Zbigniew M.Szczepiorkowski,Beth H.Shaz,NicholasBandarenko,Jeffrey L.Winters.??The new approach to assignment of ASFA categories—Introduction to the fourth special issue: Clinical applications of therapeutic apheresis(J)J. Clin. Apheresis . 2007 (3)
  • 5Tan D,Hwang W,Goh Y T.Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore. Annals of the Academy of Medicine, Singapore . 2005
  • 6张宇琦,杨秀荣,石春平,王晓梅,唐丽萍,张宝杰.血细胞分离机的治疗性临床应用与探讨[J].中国伤残医学,2012,20(2):62-62. 被引量:2
  • 7George TI.Malignant or benign leukocytosis. Hematology Am Soc Hematol Educ Program . 2012

二级参考文献11

  • 1何徐彭,徐开林,鹿群先,潘秀英,黄一虹,何祎.砷剂与化疗双诱导治疗急性早幼粒细胞白血病疗效观察[J].中华血液学杂志,2004,25(12):759-760. 被引量:3
  • 2Harris NL,Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietie and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 [ J ]. J Clin Oncol, 1999,17 ( 12 ) : 3835-3849.
  • 3张之南.血液病诊断及疗效标准[M].2版.北京:科学出版社,1999:172—174.
  • 4Lo Coco F,Avvisati G,Vignetti M,et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation : results of the AIDA-2000 trial of the Italian GIMEMA Group[J]. Blood,2004,104( 11 ) :392.
  • 5Roberts TF, Sprague K, Schenkein D, et al. Hypefleukocytosis during induction therapy with arsenic trioxide for relapsed acute premyelocytic leukemia associated with central nervors system infarction[ J].Blood ,2000,96(12) :4000-4001.
  • 6De Botton S, Dowbret H, Sanz M, et al. Incidence clinical features and outcome of all trans retinoic acid syndrome in 413 cases of newly diagnosed acute premyelocytic leukemia [ J]. Blood, 1998,92 (8) :2712-2718.
  • 7Chen Z, Chen GQ, Shen ZX, et al. Treatment of acute premyelocytic leukemia with arsenic compounds:in vitro and in vivo studies[ J]. Semin Hematol,2001,38 ( 1 ) :26-36.
  • 8Tallman MS, Nabhan CH, Feusner JH, et al. Acute promyelooytic leukemia: evolving therapeutic strategies [ J ]. Blood, 2002,99 (3) : 759-767.
  • 9Ades L, Raffoux E, Chevret S, et al. Is Ara-C required in the treatment of newly diagnosed APL? Results of a randomized trial (APL2000) [J]. Blood ,2004,104( 11 ) :105.
  • 10张鹏,王树叶,胡龙虎,邱凤芹,杨惠芬,肖彧君,李晓霞,韩雪英,周晋,刘澎.三氧化二砷治疗急性早幼粒细胞白血病七年总结——附242例分析[J].中华血液学杂志,2000,21(2):67-70. 被引量:319

共引文献14

同被引文献85

引证文献10

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部